SE

SERAGEN INC

  • CIK: 0000833299
  • EIN: 04-2662345
  • Business address: 97 SOUTH ST, HOPKINTON, Massachusetts, 01748

Information

  • Mailing address
    97 SOUTH ST, HOPKINTON, Delaware, 01748
  • Phone
    5084352331
  • State location
    Massachusetts
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Filings
    N/A

About SERAGEN INC

SERAGEN INC (CIK: 0000833299) is an American company incorporated in the state of Massachusetts. Head office is located at 97 SOUTH ST, HOPKINTON, Massachusetts, 01748. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). SERAGEN INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SERAGEN INC

Filings Format Description Filed/Effective File/Film Number
SC 13D/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0000936392-98-001199 ( Act) Size: KB		 Aug-21-1998

005-46217

98695910
15-12G Document

Notice of termination of registration of a class of securities under Section 12(g)

Acc-no: 0000936392-98-001141 ( Act) Size: KB		 Aug-12-1998

000-19855

98684159
DEFM14A Document

Definitive proxy statement relating to a merger,acquisition, or disposition

Acc-no: 0000936392-98-001007 ( Act) Size: KB		 Jul-13-1998

000-19855

98665218
SC 13D/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0000950117-98-001123 ( Act) Size: KB		 May-22-1998

005-46217

98630652
3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0000936392-98-000870 ( Act) Size: 0 KB		 May-21-1998

000-19855

98629530
SC 13D Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0000936392-98-000869 ( Act) Size: KB		 May-21-1998

005-46217

98629529
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000833299-98-000007 ( Act) Size: KB		 May-15-1998

000-19855

98625735
8-K Document

Current report filing

Acc-no: 0000833299-98-000006 ( Act) Size: KB		 May-15-1998

000-19855

98621686
DEF 14A Document

Definitive proxy statements

Acc-no: 0000833299-98-000005 ( Act) Size: KB		 Apr-27-1998

000-19855

98601858
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0000833299-98-000002 ( Act) Size: KB		 Mar-31-1998

000-19855

98581983
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000833299-97-000029 ( Act) Size: KB		 Nov-14-1997

000-19855

97722486
8-K/A Document

Amendment to Current report filing

Acc-no: 0000833299-97-000028 ( Act) Size: KB		 Nov-07-1997

000-19855

97709644
DEF 14A Document

Definitive proxy statements

Acc-no: 0000833299-97-000027 ( Act) Size: KB		 Nov-07-1997

000-19855

97709639
8-K/A Document

Amendment to Current report filing

Acc-no: 0000833299-97-000026 ( Act) Size: KB		 Nov-03-1997

000-19855

97706448
10-Q/A Document

Amendment to Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000833299-97-000025 ( Act) Size: KB		 Oct-31-1997

000-19855

97705777
10-Q/A Document

Amendment to Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000833299-97-000024 ( Act) Size: KB		 Oct-31-1997

000-19855

97705764
10-K/A Document

Amendment to Annual report pursuant to section 13 and 15(d)

Acc-no: 0000833299-97-000023 ( Act) Size: KB		 Oct-31-1997

000-19855

97705751
10-Q/A Document

Amendment to Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000833299-97-000022 ( Act) Size: KB		 Oct-31-1997

000-19855

97705733
10-Q/A Document

Amendment to Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000833299-97-000021 ( Act) Size: KB		 Oct-31-1997

000-19855

97705729
8-K Document

Current report filing

Acc-no: 0000833299-97-000020 ( Act) Size: KB		 Sep-25-1997

000-19855

97685419

Recent 20 filings. View all SERAGEN INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Frequently Asked Questions

Tags:

  • SERAGEN INC overview
  • SERAGEN INC job
  • SERAGEN INC stock
  • SERAGEN INC ownership
  • SERAGEN INC CEO
  • SERAGEN INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Maze Therapeutics, Inc.
Update: Jan 08, 2025
Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Sequoia Vaccines, Inc.
Update: Nov 07, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2869 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3262 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4198 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 1603 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 2601 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1458 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3149 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2015 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3792 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by